Medical News

RSS

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

As part of Kaiser Permanente's culture of continuous improvement, the organization annually recognizes outstanding projects across the nation's largest integrated health system that advance quality and patient safety. Recently, three winners were honored for their efforts in supporting patient care through technology, advanced sepsis intervention and improving early detection of diabetic retinopathy.

20 Oct 2015

APBI brachytherapy improves overall survival in selected patients with early stage breast cancer

The Groupe Européen de Curiethérapie European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) today announced results from a prospective, randomized, multicenter phase III study comparing accelerated partial breast irradiation (APBI) with interstitial multicatheter brachytherapy to whole breast irradiation (WBI).

20 Oct 2015

Road traffic crashes remain too high despite improvements in road safety

Some 1.25 million people die each year as a result of road traffic crashes, according to the WHO's Global status report on road safety 2015, despite improvements in road safety.

20 Oct 2015

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.

19 Oct 2015

Lexicon's telotristat etiprate improves social and physical function, emotional well-being in cancer patients

Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.

19 Oct 2015

Biophor receives FDA 510(k) clearance for distribution of seventh oral fluid screening assay

Biophor Diagnostics, Inc. announces that it has received FDA 510(k) clearance for sale and distribution of its seventh oral fluid screening assay based on the RapidFRET IVD Platform technology. This clearance completes the company's flagship panel for drugs of abuse screening in oral fluid.

19 Oct 2015

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, announced today that Enstilar has been approved by the U.S. Food and Drug Administration for the topical treatment of plaque psoriasis in adults 18 years of age and older.

19 Oct 2015

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.

19 Oct 2015

Allergan completes acquisition of AqueSys

Allergan plc, a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma.

19 Oct 2015

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sprout Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, is now available in the United States through certified physicians and pharmacies.

19 Oct 2015

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that yesterday it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.

19 Oct 2015

Sequenom enters into clinical collaboration with CU School of Medicine

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with the University of Colorado Denver, School of Medicine.

19 Oct 2015

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.

19 Oct 2015

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

A joint study by UT Southwestern Medical Center and Parkland Health & Hospital System investigators found that a multicomponent outreach program increased completion of the three-dose human papillomavirus (HPV) vaccination series that reduces the risk of cervical cancer caused by the virus.

19 Oct 2015

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida.

19 Oct 2015

Dehaier secures medical device distribution bid for rural healthcare construction project supported by CDB

Dehaier Medical Systems Ltd., which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has won a medical device distribution bid for a new rural healthcare construction project supported by China Development Bank Corp.

19 Oct 2015

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Scientists in Sweden have discovered that human intestinal flora regulates the levels of the body's main antioxidant, glutathione, which fights a host of diseases. The findings could lead to new probiotic-delivering foods, and a better understanding of the metabolic processes behind diseases such as type 2 diabetes.

19 Oct 2015

Univfy announces new IVF refund program

At the American Society for Reproductive Medicine Annual Meeting in Baltimore this year, Univfy, the global leader in predictive analytics for in vitro fertilization (IVF), announces a new program to help fertility providers qualify more patients for IVF refund programs.

19 Oct 2015

Researchers associate neuroimaging data with reading deficits in patients with left-sided stroke

Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.

19 Oct 2015

Elsevier chosen to publish AWHONN's JOGNN and Nursing for Women's Health

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, and The Association of Women's Health, Obstetric and Neonatal Nurses have announced that Elsevier will publish AWHONN's official publications, Journal of Obstetric, Gynecologic & Neonatal Nursing and Nursing for Women's Health, beginning with the 2016 volumes.

19 Oct 2015

Medical News

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

APBI brachytherapy improves overall survival in selected patients with early stage breast cancer

Road traffic crashes remain too high despite improvements in road safety

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Lexicon's telotristat etiprate improves social and physical function, emotional well-being in cancer patients

Biophor receives FDA 510(k) clearance for distribution of seventh oral fluid screening assay

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Allergan completes acquisition of AqueSys

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

Sequenom enters into clinical collaboration with CU School of Medicine

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

Dehaier secures medical device distribution bid for rural healthcare construction project supported by CDB

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Univfy announces new IVF refund program

Researchers associate neuroimaging data with reading deficits in patients with left-sided stroke

Elsevier chosen to publish AWHONN's JOGNN and Nursing for Women's Health

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News